These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Short-Chain Fatty Acids Improve Poststroke Recovery via Immunological Mechanisms. Sadler R; Cramer JV; Heindl S; Kostidis S; Betz D; Zuurbier KR; Northoff BH; Heijink M; Goldberg MP; Plautz EJ; Roth S; Malik R; Dichgans M; Holdt LM; Benakis C; Giera M; Stowe AM; Liesz A J Neurosci; 2020 Jan; 40(5):1162-1173. PubMed ID: 31889008 [TBL] [Abstract][Full Text] [Related]
27. The effect of amyloid on microglia-neuron interactions before plaque onset occurs independently of TREM2 in a mouse model of Alzheimer's disease. von Saucken VE; Jay TR; Landreth GE Neurobiol Dis; 2020 Nov; 145():105072. PubMed ID: 32890775 [TBL] [Abstract][Full Text] [Related]
28. Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease. Yin Z; Raj D; Saiepour N; Van Dam D; Brouwer N; Holtman IR; Eggen BJL; Möller T; Tamm JA; Abdourahman A; Hol EM; Kamphuis W; Bayer TA; De Deyn PP; Boddeke E Neurobiol Aging; 2017 Jul; 55():115-122. PubMed ID: 28434692 [TBL] [Abstract][Full Text] [Related]
29. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment. Nagpal R; Neth BJ; Wang S; Craft S; Yadav H EBioMedicine; 2019 Sep; 47():529-542. PubMed ID: 31477562 [TBL] [Abstract][Full Text] [Related]
30. INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia. Tsai AP; Lin PB; Dong C; Moutinho M; Casali BT; Liu Y; Lamb BT; Landreth GE; Oblak AL; Nho K Neurobiol Dis; 2021 Jun; 153():105303. PubMed ID: 33631273 [TBL] [Abstract][Full Text] [Related]
31. Early modulation of the gut microbiome by female sex hormones alters amyloid pathology and microglial function. Saha P; Weigle IQ; Slimmon N; Poli PB; Patel P; Zhang X; Cao Y; Michalkiewicz J; Gomm A; Zhang C; Tanzi RE; Dylla N; Al-Hendy A; Sisodia SS Sci Rep; 2024 Jan; 14(1):1827. PubMed ID: 38246956 [TBL] [Abstract][Full Text] [Related]
32. Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model. Huynh TV; Wang C; Tran AC; Tabor GT; Mahan TE; Francis CM; Finn MB; Spellman R; Manis M; Tanzi RE; Ulrich JD; Holtzman DM Mol Neurodegener; 2019 Oct; 14(1):37. PubMed ID: 31623648 [TBL] [Abstract][Full Text] [Related]
33. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology. Laversenne V; Nazeeruddin S; Källstig EC; Colin P; Voize C; Schneider BL Acta Neuropathol Commun; 2020 Nov; 8(1):198. PubMed ID: 33225991 [TBL] [Abstract][Full Text] [Related]
34. Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2. Ulrich JD; Finn MB; Wang Y; Shen A; Mahan TE; Jiang H; Stewart FR; Piccio L; Colonna M; Holtzman DM Mol Neurodegener; 2014 Jun; 9():20. PubMed ID: 24893973 [TBL] [Abstract][Full Text] [Related]
35. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance. Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458 [TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of apolipoproteins from murine microglia. Identification of a low density lipoprotein-like apolipoprotein J-rich but E-poor spherical particle. Xu Q; Li Y; Cyras C; Sanan DA; Cordell B J Biol Chem; 2000 Oct; 275(41):31770-7. PubMed ID: 10918055 [TBL] [Abstract][Full Text] [Related]
37. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model. Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926 [TBL] [Abstract][Full Text] [Related]
38. ApoE facilitates the microglial response to amyloid plaque pathology. Ulrich JD; Ulland TK; Mahan TE; Nyström S; Nilsson KP; Song WM; Zhou Y; Reinartz M; Choi S; Jiang H; Stewart FR; Anderson E; Wang Y; Colonna M; Holtzman DM J Exp Med; 2018 Apr; 215(4):1047-1058. PubMed ID: 29483128 [TBL] [Abstract][Full Text] [Related]
39. Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia. Xia D; Lianoglou S; Sandmann T; Calvert M; Suh JH; Thomsen E; Dugas J; Pizzo ME; DeVos SL; Earr TK; Lin CC; Davis S; Ha C; Leung AW; Nguyen H; Chau R; Yulyaningsih E; Lopez I; Solanoy H; Masoud ST; Liang CC; Lin K; Astarita G; Khoury N; Zuchero JY; Thorne RG; Shen K; Miller S; Palop JJ; Garceau D; Sasner M; Whitesell JD; Harris JA; Hummel S; Gnörich J; Wind K; Kunze L; Zatcepin A; Brendel M; Willem M; Haass C; Barnett D; Zimmer TS; Orr AG; Scearce-Levie K; Lewcock JW; Di Paolo G; Sanchez PE Mol Neurodegener; 2022 Jun; 17(1):41. PubMed ID: 35690868 [TBL] [Abstract][Full Text] [Related]
40. Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti-inflammatory activity, and the gut microbiota-liver-brain axis. Daily JW; Kang S; Park S Biofactors; 2021 Mar; 47(2):218-231. PubMed ID: 33347668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]